4//SEC Filing
Klausner Richard 4
Accession 0001415889-24-017176
CIK 0001806952other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 4:15 PM ET
Size
14.6 KB
Accession
0001415889-24-017176
Insider Transaction Report
Form 4
Klausner Richard
Director
Transactions
- Award
Option (right to buy)
2024-06-14+130,000→ 130,000 totalExercise: $2.36Exp: 2034-06-13→ Common Stock (130,000 underlying)
Holdings
- 2,967,834
Common Stock
- 685,365(indirect: Grantor)
Common Stock
Footnotes (2)
- [F1]Consists of 245,515 shares held by The Ariella Klausner Delaware Trust, 194,335 shares held by The Eli Klausner Delaware Trust and 245,515 shares held by The Olivia Klausner Delaware Trust. The Reporting Person is a grantor of each of the trusts and disclaims beneficial ownership of all shares held by the trusts except to any pecuniary interest therein. The JTC Trust Company (Delaware) Limited is the trustee of each of the trusts.
- [F2]The option shares shall vest on the earlier of (a) the date of the next annual meeting of the stockholders that occurs following June 14, 2024 (or the date immediately prior to such date if the Reporting Person's service as a director ends at such annual meeting due to the Reporting Person's failure to be reelected or the Reporting Person not standing for re-election); or (b) the first anniversary of June 14, 2024, subject to the Reporting Person providing continuous service through such date.
Documents
Issuer
Lyell Immunopharma, Inc.
CIK 0001806952
Entity typeother
Related Parties
1- filerCIK 0001591178
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 4:15 PM ET
- Size
- 14.6 KB